Suzuki Takashi, Inokuchi Ryota, Hanaoka Kazuo, Suka Machi, Yanagisawa Hiroyuki
Department of Anesthesiology and Pain Relief Center, JR Tokyo General Hospital, Tokyo, Japan.
Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, Tokyo, Japan.
SAGE Open Med. 2018 Feb 9;6:2050312118756804. doi: 10.1177/2050312118756804. eCollection 2018.
Minimally invasive epiduroscopy has recently been reported as an effective treatment procedure for chronic and intractable low back pain. However, no study has determined safe anesthetics for monitored anesthesia care during epiduroscopy. We aimed to compare and evaluate conventional monitored anesthesia care drugs with dexmedetomidine.
A retrospective study including all patients who underwent epiduroscopy at the JR Tokyo General Hospital from April 2011 to March 2016 was designed. The epiduroscopy procedures were performed under anesthesia with dexmedetomidine plus fentanyl (dexmedetomidine group) or droperidol plus fentanyl (neuroleptanalgesia group). Patients who received analgesics other than fentanyl, another analgesic combined with fentanyl, any sedative other than dexmedetomidine or droperidol, or who had incomplete data were excluded. We compared (1) the type and dose of medication during the epiduroscopy and (2) the incidence of postoperative nausea and vomiting.
We identified 45 patients (31 and 14 in the dexmedetomidine and neuroleptanalgesia groups, respectively) with a mean age of 69.0 years. The two groups had comparable characteristics, such as age, sex, body mass index, the American Society of Anesthesiologists Physical Status, analgesics used in the clinic, comorbidities, history of smoking, and the duration of anesthesia. The dexmedetomidine group received a significantly lower fentanyl dose during surgery (126 ± 14 vs 193 ± 21 µg, mean ± standard deviation, p = 0.014) and exhibited a significantly lower incidence of postoperative nausea and vomiting (1 vs 3, p = 0.047) than the neuroleptanalgesia group.
This study involved elderly patients, and the use of dexmedetomidine in monitored anesthesia care during epiduroscopy procedures in these patients may reduce the required fentanyl dose during surgery and the incidence of postoperative nausea and vomiting. This strategy may help prevent respiratory depression and aspiration.
最近有报道称,微创硬膜外腔镜检查是治疗慢性顽固性腰痛的一种有效治疗方法。然而,尚无研究确定硬膜外腔镜检查期间用于监护麻醉的安全麻醉剂。我们旨在比较和评估传统监护麻醉药物与右美托咪定。
设计一项回顾性研究,纳入2011年4月至2016年3月在东京JR总医院接受硬膜外腔镜检查的所有患者。硬膜外腔镜检查在右美托咪定加芬太尼麻醉(右美托咪定组)或氟哌利多加芬太尼麻醉(神经安定镇痛组)下进行。排除接受除芬太尼以外的镇痛药、芬太尼联合其他镇痛药、除右美托咪定或氟哌利多以外的任何镇静剂或数据不完整的患者。我们比较了(1)硬膜外腔镜检查期间的用药类型和剂量,以及(2)术后恶心呕吐的发生率。
我们确定了45例患者(右美托咪定组31例,神经安定镇痛组14例),平均年龄69.0岁。两组在年龄、性别、体重指数、美国麻醉医师协会身体状况、临床使用的镇痛药、合并症、吸烟史和麻醉持续时间等方面具有可比特征。右美托咪定组手术期间芬太尼剂量显著低于神经安定镇痛组(126±14 vs 193±21μg,平均值±标准差,p = 0.014),术后恶心呕吐发生率也显著低于神经安定镇痛组(1例 vs 3例,p = 0.047)。
本研究涉及老年患者,在这些患者的硬膜外腔镜检查过程中,监护麻醉中使用右美托咪定可能会降低手术期间所需的芬太尼剂量以及术后恶心呕吐的发生率。这种策略可能有助于预防呼吸抑制和误吸。